EPID Multiple Sclerosis Pregnancy Study

NCT02749396 · clinicaltrials.gov ↗

COMPLETED

Status

2089

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Betaseron (Interferon beta-1b, BAY86-5046), Bayer HealthCare AG
DRUG: Extavia (interferon beta-1b), Novartis Pharma AG
DRUG: Rebif (interferon beta-1a), Merck Serono Europe Ltd
DRUG: Plegridy (peginterferon beta-1a), Biogen Idec Ltd
DRUG: Avonex (interferon beta-1a), Biogen Idec Ltd
DRUG: MSDMDs other than Betaseron (Interferon beta-1b, BAY86-5046)
OTHER: No MSDMDs therapy (control)

Sponsor

Bayer

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]